ADBiotech Co., Ltd. (KOSDAQ:179530)

South Korea · Delayed Price · Currency is KRW

3,100.00

+585.00 (23.26%)

At close: Apr 3, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Biotechnology Sector		8.60B	10.63B	-	-
Biotechnology Sector Growth		-19.12%	-	-	-
Online Platform Sector		1.88B	-	-	-
Consolidation Adjustment		-2.03M	-	-	-
Vitamins & Nutrition Products		-	-	11.84B	9.82B
Vitamins & Nutrition Products Growth		-	-	20.63%	-
Total		10.47B	10.63B	11.84B	9.82B
Total Growth		-1.50%	-10.21%	20.63%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
South Korea		8.07B	8.28B	9.19B	7.52B
South Korea Growth		-2.45%	-9.95%	22.27%	-
Asia		2.40B	2.35B	2.65B	2.30B
Asia Growth		1.84%	-11.12%	15.25%	-
Total		10.47B	10.63B	11.84B	9.82B
Total Growth		-1.50%	-10.21%	20.63%	-

Source: S&P Global Market Intelligence.